Counde O'Yang

USPTO Granted Patents = 38 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 118(Granted Patents)

Location History:

Mountain View, CA (US) (1986)
Sunnyvale, CA (US) (1991 - 2011)

Company Filing History:

Ro&cacute;he Palo Alto LLC

patent

4. 1 out of 168

F. Hoffmann-la Roche Ag

Years Active: 1986-2011

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7947709 - Non-nucleoside reverse transcriptase inhibitors (2011-05-24),

2. 7868031 - Propionamide compounds as antiinflammatory agents (2011-01-11),

3. 7799816 - Imidazolinylmethyl aryl sulfonamide (2010-09-21),

4. 7741326 - Indole and benzofuran 2-carboxamide derivatives and uses thereof (2010-06-22),

5. 7566708 - Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors (2009-07-28),

6. 7435731 - Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same (2008-10-14),

7. 7432283 - [object Object] (2008-10-07),

8. 7414059 - Pyrazolyl and imidazolyl pyrimidines as CRF antagonists (2008-08-19),

9. 7407980 - Imidazolinylmethyl aralkylsulfonamides (2008-08-05),

10. 7365211 - Heterocyclic GABAA subtype selective receptor modulators (2008-04-29),

11. 7348322 - Glucocorticoid receptor modulators as antiinflammatory agents (2008-03-25),

12. 7312230 - Carboxylic acid derivatives as IP antagonists (2007-12-25),

13. 7307082 - Heterocyclic derivatives as CRF antagonists (2007-12-11),

14. 7279498 - Substituted aryl amides as IP antagonists (2007-10-09),

15. 7268146 - Ring fused pyrazole derivatives as CRF antagonists (2007-09-11),

Title: Counde O'Yang: Innovator in Pharmaceutical Patents

Introduction

Counde O'Yang, based in Sunnyvale, CA, is a prolific inventor with a remarkable portfolio of 38 patents. His contributions to the field of pharmaceuticals have been significant, particularly in the areas of anti-HIV treatments and anti-inflammatory agents.

Latest Patents

Among his latest innovations are groundbreaking patents related to non-nucleoside reverse transcriptase inhibitors. These compounds, defined by a specific formula, have shown efficacy in inhibiting HIV-1 reverse transcriptase, offering new avenues for the prevention and treatment of HIV-1 infections, as well as AIDS and AIDS-related complex (ARC). O'Yang's inventions also include propionamide compounds designed as anti-inflammatory agents, which possess potential therapeutic applications.

Career Highlights

O'Yang's impressive career includes key roles at esteemed organizations such as Roche Palo Alto LLC and Syntex (U.S.A.) Inc., where he has furthered his research and innovation in pharmaceutical sciences. His work has had a profound impact on the development of vital medications and therapeutic strategies.

Collaborations

Throughout his career, O'Yang has collaborated with esteemed colleagues, including Francisco Javier Lopez-Tapia and Alexander Victor Muehldorf. These partnerships have helped to enhance the innovative processes and outcomes of their respective research projects.

Conclusion

Counde O'Yang's extensive patent portfolio and his commitment to advancing pharmaceutical research highlight his integral role in tackling critical health challenges. His ongoing contributions continue to inspire and shape the future of medical therapies.

This text is generated by artificial intelligence and may not be accurate.